CAD 1.38
(-5.48%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -188.54 Thousand CAD | -150.5% |
2022 | -75.26 Thousand CAD | -320.91% |
2021 | -17.88 Thousand CAD | 12.51% |
2020 | -20.43 Thousand CAD | -2.71% |
2019 | -19.9 Thousand CAD | -3.02% |
2018 | -19.31 Thousand CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -43.33 Thousand USD | -30.61% |
2024 Q2 | - USD | 100.0% |
2023 Q2 | -43 Thousand USD | 52.44% |
2023 FY | -188.54 Thousand CAD | -150.5% |
2023 Q3 | -22.08 Thousand USD | 48.64% |
2023 Q4 | -33.17 Thousand USD | -50.22% |
2023 Q1 | -90.41 Thousand USD | -209.16% |
2022 Q2 | -12.45 Thousand CAD | -160.49% |
2022 Q1 | -4781.00 CAD | -0.89% |
2022 Q4 | -29.24 Thousand CAD | -1.59% |
2022 Q3 | -28.78 Thousand CAD | -131.15% |
2022 FY | -75.26 Thousand CAD | -320.91% |
2021 FY | -17.88 Thousand CAD | 12.51% |
2021 Q4 | -4739.00 CAD | -4.71% |
2021 Q2 | -4373.00 CAD | -3.04% |
2021 Q1 | -4244.00 CAD | 0.0% |
2021 Q3 | -4526.00 CAD | -3.5% |
2020 Q4 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | -20.43 Thousand CAD | -2.71% |
2020 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | -19.9 Thousand CAD | -3.02% |
2019 Q2 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 FY | -19.31 Thousand CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Arch Biopartners Inc. | -128.99 Thousand CAD | -46.166% |
Covalon Technologies Ltd. | 14.36 Million CAD | 101.313% |
Hemostemix Inc. | -223.00 CAD | -84448.43% |
Universal Ibogaine Inc. | 1.07 Million CAD | 117.608% |
Kane Biotech Inc. | 109.47 Thousand CAD | 272.233% |
MedMira Inc. | -434.91 Thousand CAD | 56.648% |
Marvel Biosciences Corp. | -887.51 Thousand CAD | 78.756% |
NervGen Pharma Corp. | -145 Thousand CAD | -30.027% |